media.alsearsmd.com

Alz Spoonful Refs

REFERENCES
  1. Newport M, et al. “A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer’s” Alzheimers Dement. 2015;11(1):99-103..
  2. Chen L. “The Most Profitable Industries in 2016.” Dec 21, 2015.
  3. Page K, et al. “Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia.” 2009;58(5):1237-1244.
  4. Cunnane S, et al. “Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer’s disease.” N.Y. Acad. Sci. 14 January 2016.
  5. Henderson S, et al. “Effects of β-hydroxybutyrate on cognition in memory-impaired adults.” Neurology of Aging. April 2004.
  6. Bailey M. “After many disappointments, the search of Alzheimer’s drugs is more urgent than ever.” The Washington Post. February 6, 2017.
  7. Babayan V. “Medium chain triglycerides and structured lipids.” 1987;22(6):417-20.
  8. Pennington Biomedical Research Center. (2014) Pennington Biomedical Helping Lead National Study Evaluating New Approach That Could Slow Progression of Alzheimer’s Disease. [Press Release]
  9. Rebello C, et al. “Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial.” BBA Clin. 2015;3:123-125.
  10. “Alzheimer basic: Plaques and Tangles.” Alzheimer’s Association.
  11. Cai Z, et al. “Autophagy dysfunction upregulates beta-amyloid peptides via enhancing the activity of y-secretase complex.” Neuropsychiatr Dis Treat. 2015;11:2091-2099.
  12. Longo V., et al. “Fasting: Molecular Mechanisms and Clinical Applications.” Cell Metab. 2014 February 4.
  13. Longo V., et al. “Fasting: Molecular Mechanisms and Clinical Applications.” Cell Metab. 2014 February 4.
  14. Su Z., et al. “Apoptosis, autophagy, necroptosis, and cancer metastasis.” Molecular Cancer.
  15. Guo Z., et al. “Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer’s disease.” Neurobiology of Disease.
  16. Berliocchi L., et al. “Autophagy impairment in a mouse model of neuropathic pain.” Molecular Pain.
  17. Horne B., et al. “Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease among Patients Undergoing Coronary Angiography.” Am J Cardiol. 2008 October 1.
  18. Lindqvist LM., et al. “Current questions and possible controversies in autophagy.” Cell Death Discovery.
  19. Horne B., et al. “Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease among Patients Undergoing Coronary Angiography.” Am J Cardiol. 2008 October 1.
  20. Aggarwal S., et al. “Differential regulation of autophagy and mitophagy in pulmonary diseases.” Am J Physiol Lung Cell Mol Physiol. July 8, 2016.
  21. Johnson J., et al. “Alternate Day Calorie Restriction Improves Clinical Findings and Reduces Markers of Oxidative Stress and Inflammation in Overweight Adults with Moderate Asthma.” Free Radic Biol Med. 2007 Mar 1.
  22. “The Nobel Assembly at Karolinska Institutet.” Nobelfö
  23. “Alzheimer’s Disease.” Harvard Stem Cell Institute.
  24. Robbins H. “Making memories stronger and more precise during aging.” Harvard Stem Cell Institute. September 1, 2016.
  25. Mikirova N, et al. “Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.” J Transl Med. 2010;8:34.
  26. “Planning for Care Costs.” Alzheimer’s Association.